$GILD News Wynn, Newmont lead gainers; Macy’
Post# of 94146
Posted On: 01/09/2015 1:03:29 PM
$GILD News
Wynn, Newmont lead gainers; Macy’s, Bed Bath & Beyond slump 11:05 a.m. Today - Sue Chang
Fifteen stocks for 2015, part 1 10:36 a.m. Today - The Trading Deck
AbbVie predicts sharp increase in earnings 4:56 p.m. Jan. 8, 2015 - MarketWatch.com
Gilead Sciences shares rise 2.4% 9:32 a.m. Jan. 6, 2015 - Sue Chang
Gilead to buy liver disease treatment from Germany's Phenex 8:39 a.m. Jan. 6, 2015 - Ciara Linnane
Gilead, CVS strike deal on Hepatitis C drugs 1:47 p.m. Jan. 5, 2015 - Russ Britt
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Are consumers getting gouged on health care? 9:35 a.m. Dec. 30, 2014 - Russ Britt
S&P 500 rises to record, but Dow snaps 7-day win streak 4:24 p.m. Dec. 29, 2014 - Sara Sjolin
Manitowoc, Gilead climb; Tesla slips 11:12 a.m. Dec. 29, 2014 - Wallace Witkowski
Mon., Dec. 29, 2014: Watch Manitowoc Stock 10:32 a.m. Dec. 29, 2014 - MarketWatch
Gilead shares up 3% as Morgan Stanley upgrades to overweight 10:07 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead shares up 2.9% in early trade 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead upgraded to overweight from equal-weight at Morgan Stanley 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
U.S. Stock Futures Fall, Following Europe's Lead 9:51 a.m. Dec. 29, 2014 - MarketWatch
Gilead Sciences, energy plays lead S&P advancers 9:34 a.m. Dec. 29, 2014 - Silvia Ascarelli
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
GoPro, Gilead Sciences, Celgene gain 11:27 a.m. Dec. 26, 2014 - MarketWatch
GoPro, Adamas climb, Cal-Maine slides 10:06 a.m. Dec. 24, 2014 - MarketWatch
Gilead's stock, up 2%, is early volume leader on Nasdaq 9:37 a.m. Dec. 24, 2014 - Tomi Kilgore
Gilled Buying Vertex Among Bold Biotech Stock Predictions for 2015 10:42 a.m. Today - TheStreet.com
Gilead Continues to Recover from Express Scripts Loss 10:04 a.m. Today - 247WallSt.com
Gilead: Focusing On The Expansion Of Its Liver Drug Portfolio 9:26 a.m. Today - Seeking Alpha
Trade-Ideas: Gilead (GILD) Is Today's Post-Market Leader Stock 5:37 p.m. Jan. 8, 2015 - TheStreet.com
AbbVie Predicts Big Profit Increase 4:52 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Hep C Drug Deal Raises Patient-Choice Concerns 3:51 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Five Stock Picks for 2015 3:00 p.m. Jan. 8, 2015 - FOXBusiness
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1 1:09 p.m. Jan. 8, 2015 - TheStreet.com
The 2015 Calendar Of NASH Trial Catalysts: Gilead Adds To Its NASH Arsenal 8:19 a.m. Jan. 8, 2015 - Seeking Alpha
Gilead to Purchase Liver Disease Program from Phenex - Analyst Blog 4:45 p.m. Jan. 7, 2015 - Zacks.com
Wells Fargo Top Biotech Stocks for 2015 2:10 p.m. Jan. 7, 2015 - 247WallSt.com
Gilead's simtuzumab an Orphan Drug for rare liver disease 1:39 p.m. Jan. 7, 2015 - Seeking Alpha
Gilead Sciences Gains Orphan Drug Status For Liver Treatment, Shares Move Higher 10:27 a.m. Jan. 7, 2015 - benzinga.com
Gilead Fires Back 10:09 a.m. Jan. 7, 2015 - Seeking Alpha
Analyst’s 8 Top Health Care Stocks for 2015 9:43 a.m. Jan. 7, 2015 - 247WallSt.com
Biotech Stock Roundup: Kite Flies High on Amgen Deal, Isis Soars on J&J Collaboration - Analyst Blog 9:09 a.m. Jan. 7, 2015 - Zacks.com
Galectin up on Phase 1 results in NASH 8:50 a.m. Jan. 7, 2015 - Seeking Alpha
Update: Gilead Acquires Another Drug Candidate 8:50 a.m. Jan. 7, 2015 - Seeking Alpha
Gilead Sciences' New Contract Exclusivity Helps The Shares Advance 8:10 a.m. Jan. 7, 2015 - Seeking Alpha
'Fast Money' Recap: Another Day, Another Market Drop on Falling Oil 5:00 a.m. Jan. 7, 2015 - TheStreet.com
Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials 8:45 a.m. Today - PR Newswire - PRF
Earnings Forecast for Apple, Alibaba, Twitter, Gilead Sciences, Michael Kors, and Tesla 8:45 a.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases 8:31 a.m. Jan. 6, 2015 - BusinessWire - BZX
Factors Moving Markets: Complementary Reports on United Parcel Service, Gilead, Manitowoc, EMC Corporation, and LiveDeal 9:10 a.m. Dec. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma 8:55 a.m. Dec. 30, 2014 - PR Newswire - PRF
Gilead Announces Amended Agreements With Janssen to Develop and Commercialize Tenofovir Alafenamide-Based Single Tablet Regimens for HIV Treatment 8:30 a.m. Dec. 29, 2014 - BusinessWire - BZX
Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver 9:31 a.m. Dec. 23, 2014 - PR Newswire - PRF
AHF Lauds Express Scripts for Dropping Gilead’s Sovaldi in Favor of Cheaper Hepatitis C Treatment 9:01 a.m. Dec. 23, 2014 - BusinessWire - BZX
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for Apple, Halliburton, American Realty Capital Properties, Gilead Sciences, Zynga, and Bank of America 8:45 a.m. Dec. 16, 2014 - PR Newswire - PRF
Philippe C. Bishop, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutics 8:30 a.m. Dec. 15, 2014 - BusinessWire - BZX
Critical Alerts For Abercrombie & Fitch, Whole Foods Market, Gilead Sciences, JC Penney and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Dec. 10, 2014 - PR Newswire - PRF
Class Action Lawsuit Challenges the Exorbitant Pricing of Gilead's Hepatitis-C Drug Sovaldi 6:39 p.m. Dec. 9, 2014 - PR Newswire - PRF
BetterInvesting Magazine Releases February Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use 4:43 p.m. Dec. 9, 2014 - PR Newswire - PRF
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council 9:15 a.m. Dec. 9, 2014 - PR Newswire - PRF
Gilead Presents Follow-up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma 10:00 a.m. Dec. 8, 2014 - BusinessWire - BZX
Reveal Earnings Forecast for Gilead Sciences, Apple, Transocean, Halliburton, Ctrip, and Sirius XM 8:45 a.m. Dec. 8, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for Gilead Sciences, Kinder Morgan, JD.Com, Sirius XM, Apple, and Plug Power 8:45 a.m. Dec. 4, 2014 - PR Newswire - PRF
Earnings Forecast Reports for Apple, Alibaba, Kinder Morgan, Gilead Sciences, Plug Power, and Yahoo 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
Wynn, Newmont lead gainers; Macy’s, Bed Bath & Beyond slump 11:05 a.m. Today - Sue Chang
Fifteen stocks for 2015, part 1 10:36 a.m. Today - The Trading Deck
AbbVie predicts sharp increase in earnings 4:56 p.m. Jan. 8, 2015 - MarketWatch.com
Gilead Sciences shares rise 2.4% 9:32 a.m. Jan. 6, 2015 - Sue Chang
Gilead to buy liver disease treatment from Germany's Phenex 8:39 a.m. Jan. 6, 2015 - Ciara Linnane
Gilead, CVS strike deal on Hepatitis C drugs 1:47 p.m. Jan. 5, 2015 - Russ Britt
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Are consumers getting gouged on health care? 9:35 a.m. Dec. 30, 2014 - Russ Britt
S&P 500 rises to record, but Dow snaps 7-day win streak 4:24 p.m. Dec. 29, 2014 - Sara Sjolin
Manitowoc, Gilead climb; Tesla slips 11:12 a.m. Dec. 29, 2014 - Wallace Witkowski
Mon., Dec. 29, 2014: Watch Manitowoc Stock 10:32 a.m. Dec. 29, 2014 - MarketWatch
Gilead shares up 3% as Morgan Stanley upgrades to overweight 10:07 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead shares up 2.9% in early trade 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead upgraded to overweight from equal-weight at Morgan Stanley 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
U.S. Stock Futures Fall, Following Europe's Lead 9:51 a.m. Dec. 29, 2014 - MarketWatch
Gilead Sciences, energy plays lead S&P advancers 9:34 a.m. Dec. 29, 2014 - Silvia Ascarelli
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
GoPro, Gilead Sciences, Celgene gain 11:27 a.m. Dec. 26, 2014 - MarketWatch
GoPro, Adamas climb, Cal-Maine slides 10:06 a.m. Dec. 24, 2014 - MarketWatch
Gilead's stock, up 2%, is early volume leader on Nasdaq 9:37 a.m. Dec. 24, 2014 - Tomi Kilgore
Gilled Buying Vertex Among Bold Biotech Stock Predictions for 2015 10:42 a.m. Today - TheStreet.com
Gilead Continues to Recover from Express Scripts Loss 10:04 a.m. Today - 247WallSt.com
Gilead: Focusing On The Expansion Of Its Liver Drug Portfolio 9:26 a.m. Today - Seeking Alpha
Trade-Ideas: Gilead (GILD) Is Today's Post-Market Leader Stock 5:37 p.m. Jan. 8, 2015 - TheStreet.com
AbbVie Predicts Big Profit Increase 4:52 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Hep C Drug Deal Raises Patient-Choice Concerns 3:51 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Five Stock Picks for 2015 3:00 p.m. Jan. 8, 2015 - FOXBusiness
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1 1:09 p.m. Jan. 8, 2015 - TheStreet.com
The 2015 Calendar Of NASH Trial Catalysts: Gilead Adds To Its NASH Arsenal 8:19 a.m. Jan. 8, 2015 - Seeking Alpha
Gilead to Purchase Liver Disease Program from Phenex - Analyst Blog 4:45 p.m. Jan. 7, 2015 - Zacks.com
Wells Fargo Top Biotech Stocks for 2015 2:10 p.m. Jan. 7, 2015 - 247WallSt.com
Gilead's simtuzumab an Orphan Drug for rare liver disease 1:39 p.m. Jan. 7, 2015 - Seeking Alpha
Gilead Sciences Gains Orphan Drug Status For Liver Treatment, Shares Move Higher 10:27 a.m. Jan. 7, 2015 - benzinga.com
Gilead Fires Back 10:09 a.m. Jan. 7, 2015 - Seeking Alpha
Analyst’s 8 Top Health Care Stocks for 2015 9:43 a.m. Jan. 7, 2015 - 247WallSt.com
Biotech Stock Roundup: Kite Flies High on Amgen Deal, Isis Soars on J&J Collaboration - Analyst Blog 9:09 a.m. Jan. 7, 2015 - Zacks.com
Galectin up on Phase 1 results in NASH 8:50 a.m. Jan. 7, 2015 - Seeking Alpha
Update: Gilead Acquires Another Drug Candidate 8:50 a.m. Jan. 7, 2015 - Seeking Alpha
Gilead Sciences' New Contract Exclusivity Helps The Shares Advance 8:10 a.m. Jan. 7, 2015 - Seeking Alpha
'Fast Money' Recap: Another Day, Another Market Drop on Falling Oil 5:00 a.m. Jan. 7, 2015 - TheStreet.com
Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials 8:45 a.m. Today - PR Newswire - PRF
Earnings Forecast for Apple, Alibaba, Twitter, Gilead Sciences, Michael Kors, and Tesla 8:45 a.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases 8:31 a.m. Jan. 6, 2015 - BusinessWire - BZX
Factors Moving Markets: Complementary Reports on United Parcel Service, Gilead, Manitowoc, EMC Corporation, and LiveDeal 9:10 a.m. Dec. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma 8:55 a.m. Dec. 30, 2014 - PR Newswire - PRF
Gilead Announces Amended Agreements With Janssen to Develop and Commercialize Tenofovir Alafenamide-Based Single Tablet Regimens for HIV Treatment 8:30 a.m. Dec. 29, 2014 - BusinessWire - BZX
Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver 9:31 a.m. Dec. 23, 2014 - PR Newswire - PRF
AHF Lauds Express Scripts for Dropping Gilead’s Sovaldi in Favor of Cheaper Hepatitis C Treatment 9:01 a.m. Dec. 23, 2014 - BusinessWire - BZX
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for Apple, Halliburton, American Realty Capital Properties, Gilead Sciences, Zynga, and Bank of America 8:45 a.m. Dec. 16, 2014 - PR Newswire - PRF
Philippe C. Bishop, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutics 8:30 a.m. Dec. 15, 2014 - BusinessWire - BZX
Critical Alerts For Abercrombie & Fitch, Whole Foods Market, Gilead Sciences, JC Penney and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Dec. 10, 2014 - PR Newswire - PRF
Class Action Lawsuit Challenges the Exorbitant Pricing of Gilead's Hepatitis-C Drug Sovaldi 6:39 p.m. Dec. 9, 2014 - PR Newswire - PRF
BetterInvesting Magazine Releases February Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use 4:43 p.m. Dec. 9, 2014 - PR Newswire - PRF
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council 9:15 a.m. Dec. 9, 2014 - PR Newswire - PRF
Gilead Presents Follow-up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma 10:00 a.m. Dec. 8, 2014 - BusinessWire - BZX
Reveal Earnings Forecast for Gilead Sciences, Apple, Transocean, Halliburton, Ctrip, and Sirius XM 8:45 a.m. Dec. 8, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for Gilead Sciences, Kinder Morgan, JD.Com, Sirius XM, Apple, and Plug Power 8:45 a.m. Dec. 4, 2014 - PR Newswire - PRF
Earnings Forecast Reports for Apple, Alibaba, Kinder Morgan, Gilead Sciences, Plug Power, and Yahoo 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼